Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Natera Inc (NQ: NTRA )

55.52 +1.26 (+2.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 963,945
Open 54.46
Bid (Size) 52.35 (1)
Ask (Size) 55.50 (1)
Prev. Close 54.26
Today's Range 53.90 - 56.26
52wk Range 27.35 - 59.75
Shares Outstanding 113,285,675
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma
From Natera, Inc.
Via Business Wire
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace

Performance

YTD
+44.25%
+44.25%
1 Month
+14.36%
+14.36%
3 Month
+36.65%
+36.65%
6 Month
+24.85%
+24.85%
1 Year
+33.94%
+33.94%

More News

Read More
Catalent Stock Showing Improved Relative Strength Rating
Via Investor's Business Daily
The Latest Analyst Ratings for Natera
Via Benzinga
Natera's Earnings Outlook
Via Benzinga
Why Natera Stock Is Leading Its Industry Group With A 17% Jump Today
Via Investor's Business Daily
Natera Announces Commercial Payor Coverage for Signatera™
From Natera, Inc.
Via Business Wire
Natera Reports Fourth Quarter and Full Year 2022 Financial Results
From Natera, Inc.
Via Business Wire
Natera to Participate in Upcoming Investor Conferences
From Natera, Inc.
Via Business Wire
Natera Appoints Ruth E. Williams-Brinkley to its Board of Directors
From Natera, Inc.
Via Business Wire
Earnings Scheduled For February 28, 2023
Via Benzinga
Natera Announces Fourth Quarter and Fiscal 2022 Earnings Conference Call
From Natera, Inc.
Via Business Wire
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Medicare Extends Coverage of Natera’s Signatera™ MRD Test to Breast Cancer
From Natera, Inc.
Via Business Wire
New Paper Highlights Clinical Utility of Natera’s Renasight™ Test in the Management of Kidney Disease
From Natera, Inc.
Via Business Wire
New Signatera™ MRD Data in Gastrointestinal Cancers to be Presented at the ASCO GI Symposium 2023
From Natera, Inc.
Via Business Wire
Raymond James Upgrades Natera & Myriad Genetics, While Downgrading This Stock
Via Benzinga
Natera Announces Publication of Prospective, Multi-Site CIRCULATE Study in Nature Medicine Demonstrating Signatera’s Ability to Predict Chemotherapy Benefit in Colorectal Cancer
From Natera, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023
Via Benzinga
Natera to Webcast Live Presentation at the 41st Annual J.P. Morgan Healthcare Conference
From Natera, Inc.
Via Business Wire
Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant Patients
From Natera, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday
Via Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.